Table 1.
Category | Class | Subtypes | Examples |
---|---|---|---|
Corticosteroids | Corticosteroids | – | Prednisolone Methylprednisolone Iluvien Ozurdex Retisert |
Second-line agents | T-cell inhibitors | Calcineurin inhibitor | Cyclosporine Tacrolimus Voclosporin |
mTOR inhibitor | Everolimus Sirolimus |
||
Antimetabolites | Purine antagonist DHFR inhibitor IMPDH inhibitor |
Azathioprine Methotrexate Mycophenolate mofetil |
|
Alkylating agents | – | Chlorambucil Cyclophosphamide |
|
Biologics | Anti-TNF | Anti-TNFα Anti-TNFα and β |
Adalimumab Certolizumab Golimumab Infliximab Etanercept |
Other biologic agents | Anti-CD11a Anti-CD20 Anti-CD28 Anti-CD52 Anti-IL1 Anti-IL1β |
Efalizumab Rituximab Abatacept Alemtuzumab Anakinra Canakinumab Gevokizumab |
|
Anti-IL2 Anti-IL6 Anti-IL17A Interferons S1P inhibitor VEGF inhibitors |
Daclizumab Tocilizumab Secukinumab Interferon α/β Fingolimod Aflibercept Bevacizumab Ranibizumab |
||
Other agents | Other | – | IVIG |
Abbreviations: CD, cluster of differentiation; DHFR, dihydrofolate reductase; IL, interleukin; IMPDH, inosine monophosphate dehydrogenase; IVIG, intravenous immunoglobulin; mTOR, mammalian target of rapamycin; S1P, sphingosine-1-phosphate; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.